OpenFilings

ALNYLAM PHARMACEUTICALS, INC.

Form10-K

Report Period2022-12-31

Date Filed2023-02-23

Time Filed08:19:23

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.41
EX-10.46
EX-10.48
EX-10.60
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
Filing on SEC Edgar